Morimoto A, Nakamori T, Watanabe T, Ono T, Murakami N
Department of Physiology, Yamaguchi University School of Medicine, Japan.
Am J Physiol. 1988 Apr;254(4 Pt 2):R633-40. doi: 10.1152/ajpregu.1988.254.4.R633.
To distinguish pattern differences in experimentally induced fevers, we investigated febrile responses induced by intravenous (IV), intracerebroventricular (ICV), and intra-preoptic/anterior hypothalamic (POA) administration of bacterial endotoxin (lipopolysaccharide, LPS), endogenous pyrogen (EP), human recombinant interleukin-1 alpha (IL-1), and prostaglandins E2 and F2 alpha (PGE2 and PGF2 alpha). Intravenous LPS, EP, or IL-1 in high concentrations caused biphasic fever. In low concentrations, they induced only the first phase of fever. Latency to onset and time to first peak of fever induced by IV injection of LPS or EP were almost the same as those after ICV or POA injection of PGE2. Fever induced by ICV or POA administration of LPS, EP, IL-1, or PGF2 alpha had a long latency to onset and a prolonged time course. There were significant differences among the latencies to fever onset exhibited by groups that received ICV or POA injections of LPS, EP, or PGF2 alpha and by groups given IV injections of LPS or EP and ICV or POA injections of PGE2. Present observations indicate different patterns of fever produced by several kinds of pyrogens when given by various routes. These results permit us to consider the possibility that there are several mediators or multiprocesses underlying the pathogenesis of fever.
为了区分实验性诱导发热中的模式差异,我们研究了通过静脉内(IV)、脑室内(ICV)以及视前区/下丘脑前部(POA)注射细菌内毒素(脂多糖,LPS)、内源性致热原(EP)、人重组白细胞介素-1α(IL-1)以及前列腺素E2和F2α(PGE2和PGF2α)所诱导的发热反应。静脉注射高浓度的LPS、EP或IL-1会引起双相热。低浓度时,它们仅诱导发热的第一阶段。静脉注射LPS或EP所诱导的发热的起始潜伏期和首次达到峰值的时间与脑室内或视前区/下丘脑前部注射PGE2后的情况几乎相同。脑室内或视前区/下丘脑前部注射LPS、EP、IL-1或PGF2α所诱导的发热具有较长的起始潜伏期和较长的病程。接受脑室内或视前区/下丘脑前部注射LPS、EP或PGF2α的组与接受静脉注射LPS或EP以及脑室内或视前区/下丘脑前部注射PGE2的组在发热起始潜伏期方面存在显著差异。目前的观察结果表明,多种致热原通过不同途径给药时会产生不同的发热模式。这些结果使我们能够考虑在发热发病机制中存在多种介质或多过程的可能性。